2022 Is stem cell transplantation safe and effective in multiple sclerosis? Group Autoimmune Diseases Working Party (ADWP) 1st listed author Basil Sharrack Journal BMJ.
2022 Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches Group Autoimmune Diseases Working Party (ADWP) 1st listed author Elisabetta Xue Journal Cells.
2022 Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation Group Autoimmune Diseases Working Party (ADWP) Paediatric Diseases Working Party (PDWP) 1st listed author Federica R. Achini-Gutzwiller Journal BJHaem
2022 Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Nicola Polverelli Journal Lancet Haematol.
2022 Haploidentical versus matched unrelated donor transplants using post-transplant cyclophosphamide for lymphomas Group Lymphoma Working Party (LWP) 1st listed author Alberto Mussetti Journal Transplant Cell Ther.
2022 New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies Group Autoimmune Diseases Working Party (ADWP) 1st listed author Matteo Doglio Journal J Allergy Clin Immunol.
2022 ATG or no ATG? - survey of clinical practice in EBMT centers on behalf of the Transplant Complications Working Party of EBMT Group Transplant Complications Working Party (TCWP) 1st listed author Agnieszka Piekarska Journal Bone Marrow Transplant.
2022 Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT Group Transplant Complications Working Party (TCWP) 1st listed author Ivan Moiseev Journal Bone Marrow Transplant.
2022 Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Joanna Drozd-Sokolowska Journal Bone Marrow Transplant.
2022 Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Carmelo Gurnari Journal Bone Marrow Transplant.
2022 New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectiois Diseases Working Pary of EBMT Group Infectious Diseases Working Party (IDWP) 1st listed author Simone Cesaro Journal Bone Marrow Transplant.
2022 Post-transplant Cyclophosphamide in Acute Leukemia Patients Receiving more than 5/10 HLA-Mismatched Allogeneic Hematopoietic Cell Transplantation from Related Donors: a Study on behalf of the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Michele Wieczorek Journal Am J Hematol.